Operator of a cloud-based biomedical analytics platform intended to support the management of chronic diseases. The company's platform supports advanced clinical research and helps bench-marking clinic outcome data across regions and countries, enabling clinical, research and policy professionals to sustain ongoing integrated care for chronic diseases.
Developer of a digital healthcare company designed to improve patient outcomes by generating insights from real-world data to support the discovery and development of new medicines. The company develops clinically validated software applications powered by artificial intelligence including prescribed digital therapeutics and hospital systems for clinical care that connect patients, clinicians and researchers, generating large databases of phenotypic data, enabling discovery research companies to generate maximum revenue from the healthcare segment.
Oxford, United KingdomHealthcare
Partner Programs
Cell and Gene Therapy Facility Commercial Services
Developer of antiviral drugs and vaccines designed for respiratory and enteric diseases. The company offers testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Operator of a cloud-based biomedical analytics platform intended to support the management of chronic diseases. The company's platform supports advanced clinical research and helps bench-marking clinic outcome data across regions and countries, enabling clinical, research and policy professionals to sustain ongoing integrated care for chronic diseases.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Europe where harmonised real-world data is used by the healthcare community to more rapidly generate high quality insights that improve outcomes for patients.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.